TMCnet News
Global Markets for Medical Imaging Reagents and Analysis Equipment -- Focus on UltrasoundNEW YORK, Dec. 20, 2012 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Markets for Medical Imaging Reagents and Analysis Equipment -- Focus on Ultrasound http://www.reportlinker.com/p01057685/Global-Markets-for-Medical-Imaging-Reagents-and-Analysis-Equipment----Focus-on-Ultrasound.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging INTRODUCTION STUDY OBJECTIVES BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for medical imaging technologies, which includes both the imaging systems and the contrast agents. The key objective is to present a comprehensive analysis and future direction of imaging techniques as an important tool for the usage in medical diagnostic procedures. This report explores present and future strategies within the medical imaging technology market, which includes X-ray imaging, ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography. The improvisation of the market as well as the setbacks and needs of the market are discussed in this report. The classifications, comparisons, advantages and disadvantages and usage of these types of diagnostic methods are also listed in this report. A detailed analysis of medical imaging industry structure has been conducted. Revenues are broken down by the region and sales figures are estimated for the five-year period from 2011 through 2017. Applications for medical imaging technologies are also discussed separately in the report, with an emphasis of the usage of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and their allotments in each category. REASONS FOR DOING THIS STUDY Extensive research and new developments in the field of medical imaging technology has improved their usage in being able to be used as a prime diagnostic tool for various diseases and other medical conditions. Modern industries continue to explore the advantages of medical imaging technologies, leading to the steady market growth due to higher production of the imaging systems. This study is an update to the one published in January 2010. R&D spending, along with increasing competition, new technologies, new advancements and new product launches have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors. Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/ technology in light of new technologies, growing competition and changing customer needs. CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE This study contributes to the areas of market growth in medical imaging (imaging systems and contrast agents) product manufacturers and users. Pharmaceutical, biotechnical companies, research institutes, hospitals and physicians will find this study to be of interest. SCOPE OF THE STUDY The scope of this study encompasses imaging technology in the field of medicine. BCC analyzes each imaging market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand, among others. METHODOLOGY Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of imaging systems and contrast agents technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends. INFORMATION SOURCES Many companies were surveyed to obtain data for this study. Included were manufacturers and end users of medical imaging technologies in various types of disease sectors industries. Data were gathered from various industry sources. BCC spoke with officials within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources. ABOUT THE AUTHOR A team of professionals in the biotechnology industry carried out this study. The project manager is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has over 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are: Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets. The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in the life sciences. She has a number of research publications to her credit. TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 1 STUDY OBJECTIVES 1 REASONS FOR DOING THIS STUDY 1 CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE 1 SCOPE OF THE STUDY 2 METHODOLOGY 2 INFORMATION SOURCES 2 ABOUT THE AUTHOR 2 RELATED BCC RESEARCH REPORTS 3 BCC ONLINE SERVICES 3 DISCLAIMER 3 CHAPTER 2 SUMMARY 5 SUMMARY TABLE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, THROUGH 2017 ($ MILLIONS) 6 SUMMARY FIGURE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, 2010-2017 ($ MILLIONS) 6 CHAPTER 3 OVERVIEW 8 DEFINITIONS 8 TYPES OF MEDICAL IMAGING 8 X-RAY IMAGING 8 History and Development of X-ray Imaging 9 TABLE 1 HISTORY AND DEVELOPMENT OF X-RAY IMAGING 9 Properties of X-ray 10 Applications of X-ray in Medicine 10 Advantages and Disadvantages of X-ray 11 TABLE 2 ADVANTAGES AND DISADVANTAGES OF X-RAY 11 ULTRASOUND 11 History and Development of Ultrasound 12 TABLE 3 HISTORY AND DEVELOPMENT OF ULTRASOUND 12 Diagnostic Applications of Ultrasound 13 Therapeutic Applications of Ultrasound 13 Advantages and Disadvantages of Ultrasound 14 TABLE 4 ADVANTAGES AND DISADVANTAGES OF ULTRASOUND 14 MAGNETIC RESONANCE IMAGING 14 History and Development of Magnetic Resonance Imaging 15 TABLE 5 HISTORY AND DEVELOPMENT OF MRI 15 Applications of Magnetic Resonance Imaging 15 Advantages and Disadvantages of MRI 16 TABLE 6 ADVANTAGES AND DISADVANTAGES OF MRI 16 COMPUTED TOMOGRAPHY 16 Applications of Computed Tomography 17 Advantages and Disadvantages of Computed Tomography 18 TABLE 7 ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY 18 POSITRON EMISSION TOMOGRAPHY 18 History and Development of Positron Emission Technology 19 TABLE 8 HISTORY AND DEVELOPMENT OF POSITRON EMISSION TECHNOLOGY 19 Advantages and Disadvantages of PET 20 TABLE 9 ADVANTAGES AND DISADVANTAGES OF PET 20 COMPARISON OF VARIOUS IMAGING MODALITIES 21 TABLE 10 DIFFERENCES BETWEEN CT AND MRI 21 TABLE 11 DIFFERENCES BETWEEN CT AND ULTRASOUND 22 TABLE 12 DIFFERENCES BETWEEN CT AND PET 22 TABLE 13 DIFFERENCES BETWEEN MRI AND X-RAY 23 CONTRAST AGENTS 23 PROPERTIES OF AN IDEAL CONTRAST AGENT 23 UNDESIRABLE EFFECTS OF CONTRAST AGENTS 23 Allergic Reactions 23 Acute Renal Failure 24 Aspiration 24 Pulmonary Edema 24 Seizure 24 CLASSIFICATION OF CONTRAST AGENTS BASED ON THEIR PROPERTIES 24 Positive Contrast Agents 24 Negative Contrast Agents 24 CLASSIFICATION OF CONTRAST AGENTS BASED ON THE TYPE OF IMAGING TECHNIQUE 25 Contrast Agents for X-ray 25 TABLE 14 ADVANTAGES AND DISADVANTAGES OF BARIUM AS CONTRAST MEDIUM 25 Contrast Agents for Magnetic Resonance Imaging 26 Nonspecific Extracellular Agents 26 TABLE 15 NONSPECIFIC EXTRACELLULAR CONTRAST AGENTS 26 Tissue-Specific Contrast Agents 27 TABLE 16 LIVER-SPECIFIC CONTRAST AGENTS 27 Contrast Agents for Ultrasound 27 PET Radiopharmaceuticals 28 TABLE 17 COMMONLY USED RADIOPHARMACEUTICALS 28 IMAGING EQUIPMENT 29 X-RAY IMAGING SYSTEM 29 FLUOROSCOPY EQUIPMENT 30 COMPUTED TOMOGRAPHY SCANNER 30 Types of Computed Tomography Scanning 30 Advances in CT Scanners /Types of CT Scanners 30 ULTRASOUND MACHINES 31 MAGNETIC RESONANCE IMAGING SYSTEM 32 POSITRON EMISSION TOMOGRAPHY EQUIPMENT 33 CHAPTER 4 REGULATORY ISSUES 35 APPROVALS IN THE FIELD OF MEDICAL IMAGING 35 NEW APPROVALS 35 TABLE 18 NEW APPROVAL OF IMAGING SYSTEMS, 2008-AUGUST 2012 35 510(K) APPROVALS 36 TABLE 19 510(K) APPROVALS FOR ULTRASOUND SYSTEMS, 2008-AUGUST 2012 36 TABLE 20 510(K) APPROVALS FOR MRI SYSTEMS, 2008-AUGUST 2012 42 TABLE 21 510(K) APPROVALS FOR X-RAY/CT SYSTEMS, 2008-AUGUST 2012 43 TABLE 22 510(K) APPROVALS FOR PET SYSTEMS, 2008-AUGUST 2012 46 RECALLS 46 TABLE 23 RECALLS FOR MAGNETIC RESONANCE IMAGING SYSTEMS 46 TABLE 24 RECALLS FOR X-RAY AND COMPUTED TOMOGRAPHY SYSTEMS, 2008--SEPTEMBER 2012 48 TABLE 25 RECALLS FOR ULTRASOUND SYSTEMS, 2008-SEPTEMBER 2012 52 TABLE 26 RECALLS FOR PET SYSTEMS, 2008--SEPTEMBER 2012 56 APPROVALS FOR CONTRAST AGENTS 57 TABLE 27 APPROVAL OF CONTRAST AGENTS 58 SAFETY ALERTS 59 TABLE 28 SAFETY ALERTS FOR CONTRAST AGENTS, 2008--SEPTEMBER 2012 59 CHAPTER 5 NEW DEVELOPMENTS/ TECHNOLOGICAL INNOVATIONS 62 TABLE 29 NEW DEVELOPMENTS IN CONTRAST AGENTS 62 TABLE 30 NEW DEVELOPMENTS IN COMPUTED TOMOGRAPHY 62 TABLE 31 NEW DEVELOPMENTS IN MAGNETIC RESONANCE IMAGING 63 TABLE 32 NEW DEVELOPMENTS IN POSITRON EMISSION TOMOGRAPHY 63 TABLE 33 NEW DEVELOPMENTS IN ULTRASOUND 64 TABLE 34 NEW DEVELOPMENTS IN RADIOGRAPHY (X-RAY, MAMMOGRAPHY AND FLUOROSCOPY) 66 CHAPTER 6 GLOBAL MARKET ANALYSIS FOR IMAGING TECHNOLOGIES 68 MARKET FOR CONTRAST AGENTS BY IMAGING TECHNOLOGY 69 MARKET OVERVIEW 69 MARKET REVENUE 71 TABLE 35 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, THROUGH 2017 ($ MILLIONS) 71 FIGURE 1 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, 2010-2017 ($ MILLIONS) 71 MARKET SHARE 72 TABLE 36 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY 2011 (%) 72 FIGURE 2 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, 2011 (%) 72 MARKET FOR IMAGING SYSTEMS BY IMAGING TECHNOLOGY 73 MARKET OVERVIEW 73 MARKET REVENUE 76 TABLE 37 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, THROUGH 2017 ($ MILLIONS) 77 FIGURE 3 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2010-2017 ($ MILLIONS) 77 MARKET SHARE 77 TABLE 38 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%) 78 FIGURE 4 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%) 78 GLOBAL MARKET FOR CONTRAST AGENTS BY REGION 78 MARKET OVERVIEW 79 MARKET REVENUE 81 TABLE 39 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, THROUGH 2017 ($ MILLIONS) 81 FIGURE 5 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, 2010-2017 ($ MILLIONS) 81 MARKET SHARE 82 TABLE 40 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%) 82 FIGURE 6 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%) 82 MARKET FOR IMAGING SYSTEMS BY REGION 82 MARKET OVERVIEW 83 MARKET REVENUE 85 TABLE 41 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, THROUGH 2017 ($ MILLIONS) 86 FIGURE 7 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, 2010-2017 ($ MILLIONS) 86 MARKET SHARE 86 TABLE 42 GLOBAL MARKET SHARES FOR IMAGING SYSTEMS, BY REGION, 2011 (%) 87 FIGURE 8 GLOBAL MARKET SHARE FOR IMAGING SYSTEMS BY REGION, 2011 (%) 87 MARKET BY APPLICATIONS 87 TABLE 43 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017 ($ MILLIONS) 92 FIGURE 9 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017 ($ MILLIONS) 92 MARKET SHARE 93 TABLE 44 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2011 (%) 94 FIGURE 10 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2011 (%) 94 CHAPTER 7 MARKET FOR ULTRASOUND IMAGING 96 MARKET FOR CONTRAST AGENTS BY REGION 96 MARKET OVERVIEW 96 MARKET REVENUE 97 TABLE 45 GLOBAL MARKET FOR ULTRASOUND REAGENTS, BY REGION, THROUGH 2017 ($ MILLIONS) 98 FIGURE 11 GLOBAL MARKET FOR ULTRASOUND REAGENTS, BY REGION, 2010-2017 (MILLIONS) 98 MARKET SHARE 98 TABLE 46 MARKET SHARE OF ULTRASOUND REAGENTS, BY REGION, 2011 (%) 99 FIGURE 12 MARKET SHARE OF ULTRASOUND REAGENTS, BY REGION, 2011 (%) 99 MARKET FOR IMAGING SYSTEMS BY REGION 99 MARKET OVERVIEW 99 MARKET REVENUE 101 TABLE 47 GLOBAL MARKET FOR ULTRASOUND SYSTEMS BY REGION, THROUGH 2017 ($ MILLIONS) 101 FIGURE 13 GLOBAL MARKET FOR ULTRASOUND SYSTEMS BY REGION, 2010-2017 ($ MILLIONS) 101 MARKET SHARE 102 TABLE 48 MARKET SHARE OF ULTRASOUND SYSTEMS, BY REGION, 2011 (%) 102 FIGURE 14 MARKET SHARE OF ULTRASOUND SYSTEMS, BY REGION, 2011 (%) 102 MARKET BY APPLICATIONS 102 TABLE 49 GLOBAL REVENUE FOR ULTRASOUND REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017 ($ MILLIONS) 104 FIGURE 15 GLOBAL REVENUE FOR ULTRASOUND REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017 ($ MILLIONS) 105 MARKET SHARE 105 TABLE 50 ULTRASOUND IMAGING MARKET SHARES, BY APPLICATION, 2011 (%) 105 FIGURE 16 ULTRASOUND IMAGING MARKET SHARES, BY APPLICATION, 2011 (%) 105 INDUSTRY STRUCTURE 106 ULTRASOUND CONTRAST AGENTS 106 Market Leaders 106 TABLE 51 LEADING MANUFACTURERS OF ULTRASOUND CONTRAST AGENTS 106 Market Share 106 TABLE 52 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2011 (%) 107 FIGURE 17 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2011 (%) 107 ULTRASOUND IMAGING SYSTEMS 107 Market Leaders 107 TABLE 53 LEADING MANUFACTURERS OF ULTRASOUND IMAGING SYSTEMS 108 Market Share 110 TABLE 54 GLOBAL MARKET SHARES OF ULTRASOUND SYSTEMS, 2011 (%) 110 FIGURE 18 GLOBAL MARKET SHARES OF ULTRASOUND SYSTEMS, 2011 (%) 111 CHAPTER 8 PATENT ANALYSIS 113 CONTRAST AGENTS 113 BY YEAR 113 TABLE 55 TOTAL NUMBER OF PATENTS FOR CONTRAST AGENTS, FROM 2008-JULY 2012 113 BY IMAGING MODALITY 113 TABLE 56 NUMBER OF PATENTS FOR CONTRAST AGENTS BY IMAGING MODALITY, FROM 2008-JULY 2012 114 BY COMPANY 114 TABLE 57 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012 114 BY COUNTRY 114 TABLE 58 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 115 BY ASSIGNEE 115 TABLE 59 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 115 IMAGING SYSTEMS 115 BY YEAR 115 TABLE 60 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 116 FIGURE 19 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 116 FIGURE 20 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 (%) 116 BY IMAGING MODALITY 117 TABLE 61 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012 117 FIGURE 21 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012 117 BY COMPANY 117 TABLE 62 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012 118 BY COUNTRY 119 TABLE 63 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 120 FIGURE 22 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 120 BY ASSIGNEE 121 TABLE 64 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 121 FIGURE 23 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 121 CHAPTER 9 DEMAND AND USE 123 CONTRAST AGENTS MARKET 123 REGULATORY ISSUES 123 BABY BOOMER GENERATION 123 INCREASING INCIDENCE OF LIFE-THREATENING DISEASES 123 COMPETITION 124 TECHNOLOGICAL ADVANCEMENTS 124 SETBACKS IN INDUSTRY 124 TRENDS IN THE IMAGING SYSTEMS MARKET 124 CHAPTER 10 COMPANY PROFILES 128 AMAG PHARMACEUTICALS INC. 128 ANALOGIC CORPORATION 128 BAYER HEALTHCARE PHARMACEUTICALS 129 BRACCO IMAGING SPA 129 COVIDIEN 129 ECHOSON SA (PL) 130 ESAOTE S.P.A 130 FONAR CORPORATION 131 GE HEALTHCARE 131 GUERBET LLC 132 HITACHI MEDICAL CORPORATION 132 HOLOGIC INC 133 LANTHEUS MEDICAL IMAGING 133 MILLENIUM TECHNOLOGIES LTD. 134 NORDION 134 PARADIGM MEDICAL INDUSTRIES INC. 134 PARAMED MEDICAL SYSTEMS INC. 135 PHILIPS HEALTHCARE 135 POSITRON CORPORATION 136 SAMSUNG MEDISON AMERICA INC 136 SHIMADZU CORPORATION 137 SIEMENS AG 137 SONOSITE INC 138 TELEMED LTD. 138 TERASON ULTRASOUND 138 TIME MEDICAL INC. 139 TOMTEC IMAGING SYSTEMS 139 TOSHIBA MEDICAL SYSTEMS CORPORATIONS 140 TRIAD ISOTOPES INC. 140 ULTRASONIX MEDICAL CORP. 141 VOLCANO CORPORATION 141 ZONARE MEDICAL SYSTEMS INC. 142 CHAPTER 11 APPENDIX I-ABBREVIATIONS 144 LIST OF TABLES SUMMARY TABLE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, THROUGH 2017 ($MILLIONS) 6TABLE 1 HISTORY AND DEVELOPMENT OF X-RAY IMAGING 9TABLE 2 ADVANTAGES AND DISADVANTAGES OF X-RAY 11TABLE 3 HISTORY AND DEVELOPMENT OF ULTRASOUND 12TABLE 4 ADVANTAGES AND DISADVANTAGES OF ULTRASOUND 14TABLE 5 HISTORY AND DEVELOPMENT OF MRI 15TABLE 6 ADVANTAGES AND DISADVANTAGES OF MRI 16TABLE 7 ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY 18TABLE 8 HISTORY AND DEVELOPMENT OF POSITRON EMISSION TECHNOLOGY 19TABLE 9 ADVANTAGES AND DISADVANTAGES OF PET 20TABLE 10 DIFFERENCES BETWEEN CT AND MRI 21TABLE 11 DIFFERENCES BETWEEN CT AND ULTRASOUND 22TABLE 12 DIFFERENCES BETWEEN CT AND PET 22TABLE 13 DIFFERENCES BETWEEN MRI AND X-RAY 23TABLE 14 ADVANTAGES AND DISADVANTAGES OF BARIUM AS CONTRAST MEDIUM 25TABLE 15 NONSPECIFIC EXTRACELLULAR CONTRAST AGENTS 26TABLE 16 LIVER-SPECIFIC CONTRAST AGENTS 27TABLE 17 COMMONLY USED RADIOPHARMACEUTICALS 28TABLE 18 NEW APPROVAL OF IMAGING SYSTEMS, 2008-AUGUST 2012 35TABLE 19 510(K) APPROVALS FOR ULTRASOUND SYSTEMS, 2008-AUGUST 2012 36TABLE 20 510(K) APPROVALS FOR MRI SYSTEMS, 2008-AUGUST 2012 42TABLE 21 510(K) APPROVALS FOR X-RAY/CT SYSTEMS, 2008-AUGUST 2012 43TABLE 22 510(K) APPROVALS FOR PET SYSTEMS, 2008-AUGUST 2012 46TABLE 23 RECALLS FOR MAGNETIC RESONANCE IMAGING SYSTEMS 46TABLE 24 RECALLS FOR X-RAY AND COMPUTED TOMOGRAPHY SYSTEMS, 2008--SEPTEMBER2012 48TABLE 25 RECALLS FOR ULTRASOUND SYSTEMS, 2008-SEPTEMBER 2012 52TABLE 26 RECALLS FOR PET SYSTEMS, 2008--SEPTEMBER 2012 56TABLE 27 APPROVAL OF CONTRAST AGENTS 58TABLE 28 SAFETY ALERTS FOR CONTRAST AGENTS, 2008--SEPTEMBER 2012 59TABLE 29 NEW DEVELOPMENTS IN CONTRAST AGENTS 62TABLE 30 NEW DEVELOPMENTS IN COMPUTED TOMOGRAPHY 62TABLE 31 NEW DEVELOPMENTS IN MAGNETIC RESONANCE IMAGING 63TABLE 32 NEW DEVELOPMENTS IN POSITRON EMISSION TOMOGRAPHY 63TABLE 33 NEW DEVELOPMENTS IN ULTRASOUND 64TABLE 34 NEW DEVELOPMENTS IN RADIOGRAPHY (X-RAY, MAMMOGRAPHY ANDFLUOROSCOPY) 66TABLE 35 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, THROUGH2017 ($ MILLIONS) 71TABLE 36 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY2011 (%) 72TABLE 37 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, THROUGH2017 ($ MILLIONS) 77TABLE 38 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%) 78TABLE 39 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, THROUGH 2017 ($MILLIONS) 81TABLE 40 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%) 82TABLE 41 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, THROUGH 2017 ($MILLIONS) 86TABLE 42 GLOBAL MARKET SHARES FOR IMAGING SYSTEMS, BY REGION, 2011 (%) 87TABLE 43 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FORVARIOUS DISEASES, THROUGH 2017 ($ MILLIONS) 92TABLE 44 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS ANDSYSTEMS USED FOR VARIOUS DISEASES, 2011 (%) 94TABLE 45 GLOBAL MARKET FOR ULTRASOUND REAGENTS, BY REGION, THROUGH 2017 ($MILLIONS) 98TABLE 46 MARKET SHARE OF ULTRASOUND REAGENTS, BY REGION, 2011 (%) 99TABLE 47 GLOBAL MARKET FOR ULTRASOUND SYSTEMS BY REGION, THROUGH 2017 ($MILLIONS) 101TABLE 48 MARKET SHARE OF ULTRASOUND SYSTEMS, BY REGION, 2011 (%) 102TABLE 49 GLOBAL REVENUE FOR ULTRASOUND REAGENTS AND SYSTEMS USED FORVARIOUS DISEASES, THROUGH 2017 ($ MILLIONS) 104TABLE 50 ULTRASOUND IMAGING MARKET SHARES, BY APPLICATION, 2011 (%) 105TABLE 51 LEADING MANUFACTURERS OF ULTRASOUND CONTRAST AGENTS 106TABLE 52 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2011 (%) 107TABLE 53 LEADING MANUFACTURERS OF ULTRASOUND IMAGING SYSTEMS 108TABLE 54 GLOBAL MARKET SHARES OF ULTRASOUND SYSTEMS, 2011 (%) 110TABLE 55 TOTAL NUMBER OF PATENTS FOR CONTRAST AGENTS, FROM 2008-JULY 2012 113TABLE 56 NUMBER OF PATENTS FOR CONTRAST AGENTS BY IMAGING MODALITY, FROM2008-JULY 2012 114TABLE 57 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012 114TABLE 58 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 115TABLE 59 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 115TABLE 60 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 116TABLE 61 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012 117TABLE 62 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012 118TABLE 63 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 120TABLE 64 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 121 LIST OF FIGURES SUMMARY FIGURE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, 2010-2017 ($ MILLIONS) 6 FIGURE 1 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, 2010-2017 ($ MILLIONS) 71 FIGURE 2 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, 2011 (%) 72 FIGURE 3 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2010-2017 ($ MILLIONS) 77 FIGURE 4 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%) 78 FIGURE 5 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, 2010-2017 ($ MILLIONS) 81 FIGURE 6 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%) 82 FIGURE 7 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, 2010-2017 ($ MILLIONS) 86 FIGURE 8 GLOBAL MARKET SHARE FOR IMAGING SYSTEMS BY REGION, 2011 (%) 87 FIGURE 9 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017 ($ MILLIONS) 92 FIGURE 10 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2011 (%) 94 FIGURE 11 GLOBAL MARKET FOR ULTRASOUND REAGENTS, BY REGION, 2010-2017 (MILLIONS) 98 FIGURE 12 MARKET SHARE OF ULTRASOUND REAGENTS, BY REGION, 2011 (%) 99 FIGURE 13 GLOBAL MARKET FOR ULTRASOUND SYSTEMS BY REGION, 2010-2017 ($ MILLIONS) 101 FIGURE 14 MARKET SHARE OF ULTRASOUND SYSTEMS, BY REGION, 2011 (%) 102 FIGURE 15 GLOBAL REVENUE FOR ULTRASOUND REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017 ($ MILLIONS) 105 FIGURE 16 ULTRASOUND IMAGING MARKET SHARES, BY APPLICATION, 2011 (%) 105 FIGURE 17 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2011 (%) 107 FIGURE 18 GLOBAL MARKET SHARES OF ULTRASOUND SYSTEMS, 2011 (%) 111 FIGURE 19 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 116 FIGURE 20 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 (%) 116 FIGURE 21 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012 117 FIGURE 22 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 120 FIGURE 23 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 121 To order this report:Medical_Imaging Industry: Global Markets for Medical Imaging Reagents and Analysis Equipment -- Focus on Ultrasound ContactNicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626 SOURCE Reportlinker |